Diabetes Research and Clinical Practice
Volume 74, Issue 2, Supplement , Pages S3-S8, 30 November 2006

Lipotoxicity versus adipotoxicity—The deleterious effects of adipose tissue on beta cells in the pathogenesis of type 2 diabetes

Diabetes Research Center, Department of Medicine, Hadassah-Hebrew University Hospital, Jerusalem 91120, Israel

published online 10 August 2006.

Abstract 

Type 2 diabetes (T2D) is thought to be a culmination of two seemingly distinct processes, insulin resistance and beta cell failure, both of which have been closely linked to obesity. Here, we focus on the various deleterious effects of obesity on the beta cell. Obesity can affect beta cells directly through the influence of elevated levels of free fatty acids (FFA), or remotely through the newly termed group of cytokines that are secreted by adipose tissue-adipokines. The direct effect of free fatty acids, termed lipotoxicity, is thought to be the result of activation of multiple intracellular signals in the beta cell, eventually leading to apoptosis and reduced insulin secretion. The remote effect of obesity is thought to be mediated by adipokines such as TNF-alpha, IL-6, leptin, omentin, visfatin, adipsin, resistin, apelin and retinol binding protein (rbp4). The currently known effects of these adipokines on beta cell function and survival are reviewed here.

Keywords: Lipotoxicity, Adipokines, Diabetes mellitus type 2, Obesity, Beta cell

To access this article, please choose from the options below

Login to an existing account or Register a new account.

  • Purchase this article for 31.50 USD (You must login/register to purchase this article)

    Online access for 24 hours. The PDF version can be downloaded as your permanent record.

  • Subscribe to this title

    Get unlimited online access to this article and all other articles in this title 24/7 for one year.

  • Claim access now

    For current subscribers with Society Membership or Account Number.

  • Visit SciVerse ScienceDirect to see if you have access via your institution.
 

PII: S0168-8227(06)00246-4

doi:10.1016/j.diabres.2006.06.004

Diabetes Research and Clinical Practice
Volume 74, Issue 2, Supplement , Pages S3-S8, 30 November 2006